Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood Advances|October 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph Pidala, Jongphil Kim, Denise Kalos, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental GroupRudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2022
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA TrialTheodore W Laetsch, Shannon L Maude, Susana Rives, et al.Haematologica|December 28, 2023
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Anna Hecht, Julia Meyer, et al.NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALLStephan A Grupp, Shannon L Maude, Susana Rives, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2019
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell TransplantationBetty K Hamilton, Ying Liu, Michael T Hemmer, et al.Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.Pageof 3